Can coeliac disease cause fatty liver? Yes, coeliac disease can contribute to fatty liver, with approximately 20–40% of adults showing elevated liver enzymes at diagnosis. This autoimmune condition, triggered by gluten, primarily affects the small intestine but can have extra-intestinal manifestations, including metabolic dysfunction-associated steatotic liver disease (MASLD). The good news is that strict adherence to a gluten-free diet often leads to normalisation of liver enzymes within 6–12 months. Understanding this connection is crucial for effective screening and management of both conditions in line with UK guidance.

Understanding the Link Between Coeliac Disease and Fatty Liver

Coeliac disease is an autoimmune condition triggered by gluten consumption, primarily affecting the small intestine. However, research increasingly demonstrates that coeliac disease can have extra-intestinal manifestations, including effects on the liver. Metabolic dysfunction-associated steatotic liver disease (MASLD), previously known as non-alcoholic fatty liver disease (NAFLD), is characterised by excessive fat accumulation in liver cells and occurs more frequently in people with coeliac disease than in the general population.

Studies suggest that approximately 20–40% of adults with coeliac disease may have elevated liver enzymes at diagnosis, indicating some degree of liver involvement. The relationship between these two conditions is complex and multifactorial. Untreated coeliac disease can lead to malabsorption of essential nutrients, chronic inflammation, and increased intestinal permeability—all factors that may contribute to liver dysfunction.

The good news is that there is substantial evidence showing that adherence to a strict gluten-free diet often leads to normalisation of liver enzymes, typically within 6–12 months. This pattern, sometimes termed 'coeliac hepatitis', suggests that the liver enzyme abnormalities are often reversible once gluten is eliminated from the diet and the intestinal lining begins to heal. However, improvement in liver fat itself is most likely when steatosis is driven by coeliac-related inflammation or malabsorption rather than by other metabolic risk factors such as obesity or type 2 diabetes.

It's important to note that whilst coeliac disease can be associated with fatty liver, not everyone with coeliac disease will develop liver problems, and fatty liver can occur independently due to other risk factors such as obesity, type 2 diabetes, or metabolic syndrome. Understanding this connection helps healthcare professionals screen appropriately and manage both conditions effectively, in line with NICE guidance on coeliac disease (NG20) and MASLD (NG49).

How Coeliac Disease Affects Liver Function

The mechanisms by which coeliac disease may affect liver function are multifaceted and involve several proposed pathophysiological processes supported by emerging evidence. Increased intestinal permeability (sometimes referred to colloquially as 'leaky gut') is a hallmark of untreated coeliac disease. When the intestinal barrier is compromised, bacterial products and inflammatory mediators can enter the portal circulation, which flows directly to the liver. This exposure is thought to trigger hepatic inflammation and may contribute to fat accumulation in liver cells.

Malabsorption is another critical factor. Coeliac disease damages the villi in the small intestine, impairing the absorption of vital nutrients including proteins, vitamins (particularly B vitamins and fat-soluble vitamins A, D, E, and K), and minerals. This nutritional deficiency can affect liver metabolism and may contribute to hepatic steatosis (fatty liver). Additionally, malabsorption may lead to weight loss in some patients, but paradoxically, the metabolic disturbances can still promote fat deposition in the liver.

Chronic systemic inflammation associated with untreated coeliac disease also plays a significant role. Inflammatory cytokines released during the autoimmune response are hypothesised to directly affect hepatocytes (liver cells) and alter lipid metabolism. Furthermore, some patients with coeliac disease may have concurrent autoimmune liver conditions, such as autoimmune hepatitis or primary biliary cholangitis, though these are less common.

The liver enzyme elevations typically seen in coeliac disease are usually mild to moderate and most commonly involve alanine aminotransferase (ALT) and aspartate aminotransferase (AST), indicating a hepatocellular pattern of injury. Occasionally, cholestatic markers such as alkaline phosphatase (ALP) or gamma-glutamyl transferase (GGT) may also be raised, which can help guide clinical suspicion towards different liver pathologies. Importantly, these abnormalities often resolve within 6–12 months of starting a gluten-free diet, suggesting that the liver damage is often functional rather than structural in the early stages.

Symptoms and Diagnosis of Liver Problems in Coeliac Disease

Many people with coeliac disease-related liver involvement are asymptomatic, with liver problems detected incidentally through routine blood tests. When symptoms do occur, they may be non-specific and overlap with general coeliac disease symptoms, making it challenging to attribute them specifically to liver dysfunction. Patients might experience:

• Fatigue and general malaise (common to both conditions)

• Right upper quadrant discomfort (though often mild)

• Unexplained weight changes

• Jaundice (yellowing of skin and eyes—rare and indicates more severe liver involvement)

Diagnosis typically begins with liver function tests (LFTs) as part of the initial coeliac disease workup or during follow-up. Elevated transaminases (ALT and AST) are the most common findings. According to NICE guideline NG20 on coeliac disease, baseline blood tests including liver function should be offered at diagnosis, with follow-up monitoring to assess response to a gluten-free diet.

If liver enzyme abnormalities are detected, further investigation is warranted to:

• Exclude other causes of liver disease, including viral hepatitis (hepatitis B and C serology), alcohol-related liver disease, medication effects, and autoimmune liver conditions (autoantibodies such as ANA, ASMA, AMA, and immunoglobulins)

• Assess the degree of liver involvement through imaging such as ultrasound, which can detect fatty infiltration

• Determine if there is significant fibrosis using non-invasive tests. NICE guideline NG49 on MASLD recommends the Enhanced Liver Fibrosis (ELF) test to assess for advanced fibrosis in adults with suspected or confirmed MASLD, with local pathways also using transient elastography (FibroScan) or blood-based fibrosis markers

In most cases of coeliac disease-related liver dysfunction, a liver biopsy is not necessary unless there is concern about alternative diagnoses or progressive liver disease despite gluten-free diet adherence. The diagnosis is often one of exclusion, supported by improvement in liver enzymes following gluten withdrawal. Healthcare professionals should maintain a high index of suspicion for liver involvement in coeliac disease and monitor liver function regularly, particularly in the first year after diagnosis. Persistent or unexplained abnormal liver function tests beyond 3 months of strict dietary adherence should follow UK abnormal LFT pathways (such as the BSG guideline on the management of abnormal liver blood tests) and may warrant specialist referral.

Managing Fatty Liver When You Have Coeliac Disease

The cornerstone of managing fatty liver in the context of coeliac disease is strict, lifelong adherence to a gluten-free diet. Evidence consistently shows that eliminating gluten allows intestinal healing, reduces systemic inflammation, and often leads to normalisation of liver enzymes within 6–12 months. Patients should work with a registered dietitian experienced in coeliac disease to ensure their diet is both gluten-free and nutritionally balanced.

Key management strategies include:

• Nutritional optimisation: Ensuring adequate intake of protein, vitamins, and minerals to support liver health and overall recovery. Supplementation may be necessary initially if deficiencies are identified.

• Weight management: If overweight or obese, gradual weight loss through healthy eating and regular physical activity can significantly improve fatty liver. Aim for a loss of at least 5% of body weight to reduce steatosis; 7–10% or more is generally needed to improve inflammation (NASH) and fibrosis, as recommended by NICE NG49.

• Regular physical activity: The UK Chief Medical Officers' Physical Activity Guidelines recommend at least 150 minutes of moderate-intensity aerobic exercise weekly, plus muscle-strengthening activities on at least 2 days per week. Reducing sedentary time is also important. Physical activity improves insulin sensitivity and helps reduce hepatic fat accumulation.

• Avoiding hepatotoxic substances: The UK low-risk drinking guideline advises consuming no more than 14 units of alcohol per week, spread over at least 3 days, with several alcohol-free days. If you have established liver disease, your clinician may advise avoiding alcohol entirely. Review all medications with your GP to identify any that might affect liver function, and report any suspected side effects via the MHRA Yellow Card scheme (https://yellowcard.mhra.gov.uk).

• Managing comorbidities: Optimising control of conditions such as type 2 diabetes, hypertension, and dyslipidaemia, which can independently contribute to fatty liver disease.

Monitoring is essential. Liver function tests should be repeated at regular intervals—typically at initial review and 12 months after starting a gluten-free diet as per NICE NG20, then annually if stable. Where MASLD is confirmed, periodic re-assessment of fibrosis risk using the ELF test may be recommended in line with NICE NG49 and local pathways. If liver enzymes fail to improve despite confirmed dietary adherence, further investigation for alternative causes of liver disease is necessary.

Patients should be aware that cross-contamination with gluten, even in small amounts, can perpetuate intestinal inflammation and potentially affect liver recovery. Reading food labels carefully, understanding hidden sources of gluten, and being cautious when eating out are all important aspects of management. Support from organisations such as Coeliac UK can provide valuable resources and guidance on dietary management and avoiding cross-contamination.

When to Seek Medical Advice About Liver Health

Whilst mild liver enzyme elevations in coeliac disease often resolve with a gluten-free diet, certain symptoms and situations warrant prompt medical attention. Seek emergency care (call 999 or go to A&E) if you experience:

• Jaundice with confusion or altered mental state (potential sign of hepatic encephalopathy)

• Severe or rapidly worsening abdominal pain

• Significant bleeding (vomiting blood or passing black, tarry stools)

• Rapidly increasing abdominal swelling (ascites)

Contact your GP urgently or call NHS 111 for advice if you experience:

• Jaundice (yellowing of the skin or whites of the eyes)

• Dark urine or pale stools

• Persistent right upper quadrant abdominal pain

• Unexplained bruising or bleeding (which may indicate impaired liver synthetic function)

You should also seek medical review if:

• Your liver enzymes remain elevated or worsen after 12 months of strict gluten-free diet adherence

• You develop new symptoms such as persistent fatigue, itching, or weight loss despite good dietary compliance

• You have additional risk factors for liver disease (such as excessive alcohol consumption, diabetes, or a family history of liver disease)

• You're taking medications that may affect the liver and notice any concerning symptoms

Regular monitoring is important even in the absence of symptoms. Attend all scheduled follow-up appointments with your GP or gastroenterologist, particularly in the first year after coeliac disease diagnosis. These appointments typically include repeat liver function tests to ensure improvement and to detect any unexpected changes early.

If you have concerns about your liver health or are struggling to maintain a gluten-free diet, don't hesitate to discuss these with your healthcare team. Early intervention and appropriate management can prevent progression of liver disease and optimise your overall health outcomes. Remember that most liver problems associated with coeliac disease are reversible with proper management, and your healthcare team is there to support you throughout your journey.

Frequently Asked Questions